Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label StudyShun Lü, Shucai Zhang, Yiping Zhang et al.|Journal of Thoracic Oncology|2022Cited by 25
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapyFengying Wu, Tao Jiang, Gongyan Chen et al.|癌症：英文版|2022Cited by 20
Humanized mice as a model for rheumatoid arthritis.Rüdiger Eming, Grete Sønderstrup, Qun Chen et al.|Arthritis Research|2002Cited by 16